AHG,Akso Health Group | Financials

Financials

AHG

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Akso Health GroupAHG

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Akso Health Group operates a social e-commerce mobile platform in China.

The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations.

It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products.

The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021.

Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Latest News >

Oil Prices Decline Despite China Stimulus, Falling U.S. Inventories and Supply Cuts as Helene Moves Through the Gulf

Oct 3, 2024

09:01 AM EDT, 09/25/2024 (MT Newswires) -- Oil prices retreated early on Wednesday, giving up some day-prior gains that came as China took steps to stimulate its economy while the second Gulf of Mexico storm in two weeks cuts into supply and a report showed a larger than expected drop in U.S. inventories. West Texas Intermediate crude oil for November...

Apogee Enterprises Agrees to Acquire UW Interco for $240 Million in Cash

Oct 3, 2024

09:03 AM EDT, 09/25/2024 (MT Newswires) -- Apogee Enterprises ( APOG ) said Wednesday that it has agreed to acquire UW Interco, a manufacturer of coated substrates, from Heartwood Partners for $240 million in cash. The architectural products provider said it expects the acquisition to contribute about $100 million of revenue with an adjusted earnings before interest, taxes, depreciation, and...

Cintas Fiscal Q1 Earnings, Revenue Rise; Fiscal 2025 Guidance Lifted

Oct 3, 2024

09:08 AM EDT, 09/25/2024 (MT Newswires) -- Cintas ( CTAS ) reported fiscal Q1 earnings Wednesday of $1.10 per diluted share, up from $0.93 a year earlier. Analysts polled by Capital IQ expected $1. Revenue for the fiscal quarter ended Aug. 31 was $2.50 billion, compared with $2.34 billion a year earlier. Analysts surveyed by Capital IQ expected $2.49 billion....

Heron Therapeutics Receives FDA Approval for Zynrelef Extended-Release Solution

Oct 3, 2024

09:04 AM EDT, 09/25/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Wednesday that the US Food and Drug Administration has approved its application for the Zynrelef extended-release solution, VAN. The company said the new VAN would replace the current vented vial spike, simplifying aseptic preparation and reducing withdrawal time to 20 to 45 seconds. It added that the...